Providence Capital Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-16
Closed -$3.44K 358
2024
Q1
$3.44K Hold
16
﹤0.01% 285
2023
Q4
$3.37K Sell
16
-12
-43% -$2.56K ﹤0.01% 285
2023
Q3
$5.61K Buy
28
+12
+75% +$2.38K ﹤0.01% 260
2023
Q2
$2.96K Sell
16
-14
-47% -$2.59K ﹤0.01% 264
2023
Q1
$5.75K Buy
+30
New +$5.42K ﹤0.01% 235
2022
Q4
Sell
-33
Closed -$6K 303
2022
Q3
$6K Hold
33
﹤0.01% 235
2022
Q2
$7K Sell
33
-34
-51% -$7.21K ﹤0.01% 221
2022
Q1
$16K Sell
67
-80
-54% -$18.8K ﹤0.01% 221
2021
Q4
$34K Sell
147
-55
-27% -$12.1K 0.01% 174
2021
Q3
$39K Buy
+202
New +$40.9K 0.01% 164

Other funds holding CME

Providence Capital Advisors's CME Position: Q2 2024 in Review

Providence Capital Advisors sold out of CME Group (CME) in Q2 2024, closing a stake of 16 shares — an estimated $3.44K sold.

Providence Capital Advisors first reported a position in CME in Q3 2021 and held it in 10 quarters. The position peaked at $39K in Q3 2021. 1,377 funds tracked by Wall St. Rank hold CME as of Q2 2024.

  • Providence Capital Advisors reported no remaining CME Group position as of Q2 2024 after selling out during the quarter.
  • Providence Capital Advisors sold 16 CME Group shares in Q2 2024, an estimated $3.44K.
  • Providence Capital Advisors first reported a position in CME Group in Q3 2021 and held it in 10 quarters.
  • Providence Capital Advisors's CME Group position peaked at $39K in Q3 2021.
  • 1,377 funds tracked by Wall St. Rank held CME Group as of Q2 2024.

Based on Providence Capital Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.